Information  X 
Enter a valid email address

LPA Group PLC (LPA)

  Print      Mail a friend       Annual reports

Friday 08 February, 2019

LPA Group PLC

Exercise of Options

RNS Number : 5359P
LPA Group PLC
08 February 2019
 

8 February 2019

LPA GROUP PLC

 ("LPA" or the "Group")

 

Exercise of Options

LPA announces that it has received notice of an exercise of options to subscribe for 231,500 new ordinary shares of 10p each. The exercise price of the options is 36 pence.

Application has been made to the London Stock Exchange for the 231,500 ordinary shares to be admitted to trading on AIM and admission is expected to occur on or around 14 February 2019.

For the purpose of the Disclosure and Transparency Rules, following the above issue of equity, the issued share capital of the Company will comprise 12,608,229 ordinary shares of 10p each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rule

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

ENQUIRIES:

LPA Group plc

  Peter Pollock, Chairman

Tel:  01799 512844

  Chris Buckenham, Chief Financial Officer

  Paul Curtis, Chief Operating Officer

Tel:  01799 512859

Tel:  01799 512858

 

Cairn Financial Advisers (Nominated Adviser)                           Tel: 020 7213 0880

James Caithie / Tony Rawlinson

 

WH Ireland (Broker)                                                                         Tel: 0117 945 3472

Mike Coe / Chris Savidge

 

Instinctif Partners (PR Adviser)                                                      Tel: 020 7457 2020

Rosie Driscoll / Christine Galloway / Mark Garraway

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
IOESSEFDAFUSEDE

a d v e r t i s e m e n t